References of "2003"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailManagement of Electric and Hybrid vehicles
Lilien, Jean-Louis ULg; Yuan, H.

(2003, November)

The battery management system (BMS) is an important feature for electric (EVs) and hybrid (HVs) vehicles. The BMS has close connections with the vehicle control and command and gives access to real time ... [more ▼]

The battery management system (BMS) is an important feature for electric (EVs) and hybrid (HVs) vehicles. The BMS has close connections with the vehicle control and command and gives access to real time power available and remaining autonomy. Such information is dramatic and comprises major inputs of the hybrid vehicle strategy on the road. The BMS is obviously related to battery modeling. Electrochemical modeling would be based on the qualification of the intrinsic chemical reactions and would help to define the parameters of the battery. Generally it is hopeless to use this model in such applications, due to all its complexities [less ▲]

Detailed reference viewed: 56 (7 ULg)
Full Text
Peer Reviewed
See detailRational to use OSIRIS® (osteoporosis index of risk) to prescreen for osteoporosis in the general population
Richy, Florent; Gourlay, M.; Ethgen, Olivier ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 67-68

Detailed reference viewed: 24 (0 ULg)
Full Text
Peer Reviewed
See detailOne-year increase of Coll 2-1 level in urine is predictive of OA progression
Henrotin, Yves ULg; Deberg, Michelle ULg; Labasse, Alain ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 12

Detailed reference viewed: 17 (7 ULg)
Full Text
Peer Reviewed
See detailAssessment of osteoporosis in daily clinical practice
Bosio-Le Goux, B.; Augendre-Ferrante, B.; Tancredi, Annalisa ULg et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 86

Detailed reference viewed: 17 (2 ULg)
Full Text
Peer Reviewed
See detailCartilage degradation and oxidative damage in OA and RA patients
Deberg, Michelle ULg; Labasse, Alain ULg; Christgau, S. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 44-45

Detailed reference viewed: 15 (4 ULg)
Full Text
Peer Reviewed
See detailPCB residues in a breast cancer patient population
Charlier, Corinne ULg; Pitance, François ULg; Plomteux, Guy ULg

in Bulletin of Environmental Contamination & Toxicology (2003), 71(5), 887-891

Detailed reference viewed: 8 (1 ULg)
Full Text
Peer Reviewed
See detailRisk assessment tools for osteoporosis: scope and limits
Richy, Florent; Gourlay, M.; Ross, P. D. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 68-69

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailPragmatic evaluation of a recently validated screening tool for osteoporosis risk: OSIRIS® (osteoporosis index of risk)
Reginster, Jean-Yves ULg; Viethel, P.; Combescure, C. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 94-95

Detailed reference viewed: 13 (1 ULg)
Peer Reviewed
See detailMMP-2 and MMP-9 activity is increased in bronchoalveolar lavage fluid of asthmatic cats
Kirschvink, N.; Delvaux, François ULg; Leemans, J. et al

in Autumn Meeting, Belgian Society of Fundamental and Clinical physiology and Pharmacology - Liège - Belgique - novembre 2003 (2003, November)

Detailed reference viewed: 4 (1 ULg)
Full Text
See detailCompléments de C++
Boman, Romain ULg

Scientific conference (2003, November)

Detailed reference viewed: 15 (10 ULg)
Full Text
Peer Reviewed
See detailDo new methods of investigation allow faster assessment of drugs efficacy in osteoarthritis?
Abadie, Eric ULg; Avouac, B.; Bouvenot, G. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 2

Detailed reference viewed: 18 (2 ULg)
Full Text
See detailPolymer stretching in a turbulent flow through Brownian Dynamics
Terrapon, Vincent ULg

Conference (2003, November)

Detailed reference viewed: 2 (0 ULg)
Full Text
Peer Reviewed
See detailQuantification of tagitinin C in Tithonia diversifolia by reversed-phase high-performance liquid chromatography.
Goffin, Eric ULg; da Cunha, Antonio Proenca; Ziemons, Eric ULg et al

in Phytochemical Analysis (2003), 14(6), 378-80

A simple, rapid and reliable reversed-phase high-performance liquid chromatographic method for the determination of tagitinin C, an anti-plasmodial sesquiterpene lactone isolated from the aerial parts of ... [more ▼]

A simple, rapid and reliable reversed-phase high-performance liquid chromatographic method for the determination of tagitinin C, an anti-plasmodial sesquiterpene lactone isolated from the aerial parts of Tithonia diversifolia, has been developed. The assay has been used to quantify tagitinin C in various extracts of the aerial parts of T. diversifolia. [less ▲]

Detailed reference viewed: 82 (12 ULg)
Full Text
Peer Reviewed
See detailEvaluation of the relationship between IGF-I, IGF-BP3, BMD and age in men presenting at a multiple risk detection campaign
Hanssens, L.; Tancredi, Annalisa ULg; De Ceulaer, F. et al

in Osteoporosis International (2003, November), 14(Suppl. 7), 90-91

Detailed reference viewed: 21 (7 ULg)
Full Text
See detailNotions d'acoustique
Embrechts, Jean-Jacques ULg

Conference (2003, November)

Detailed reference viewed: 39 (4 ULg)
Full Text
Peer Reviewed
See detailThe use of mycophenolate mofetil in liver transplant recipients
Detry, Olivier ULg; De Roover, Arnaud ULg; Delwaide, Jean ULg et al

in Expert Opinion on Pharmacotherapy (2003), 4(11), 1949-1957

Mycophenolate mofetil is an important drug in the modern immunosuppressive arsenal. Mycophenolate mofetil is the semisynthetic morpholinoethyl ester of mycophenolate acid. Mycophenolate acid prevents T ... [more ▼]

Mycophenolate mofetil is an important drug in the modern immunosuppressive arsenal. Mycophenolate mofetil is the semisynthetic morpholinoethyl ester of mycophenolate acid. Mycophenolate acid prevents T and B cell proliferation by specifically inhibiting a purine pathway required for lymphocyte division. This paper extensively reviews the experience of mycophenolate mofetil use in liver transplant recipients. In randomised trials, mycophenolate mofetil decreased the rate of acute rejection after liver transplantation, without a significant increase of septic complications. However, so far, there are no data indicating that mycophenolate mofetil increases liver transplant patient or graft survivals. Mycophenolate mofetil is interesting because of its particular side effects profile, which is very different from the other immunosuppressants. The absence of mycophenolate mofetil nephrotoxicity is of specific interest in liver recipients with impairment of renal function. The monitoring of mycophenolate acid area under the concentration time curve might be interesting to limit side effects and provide better clinical efficacy but the exact role of mycophenolate acid monitoring in liver recipients has yet to be further evaluated in large series. [less ▲]

Detailed reference viewed: 44 (8 ULg)
Full Text
Peer Reviewed
See detailTherapeutic adherence: why does it matter?
Reginster, Jean-Yves ULg

in Osteoporosis International (2003, November), 14(Suppl. 7), 102-103

Detailed reference viewed: 6 (0 ULg)
See detailBulletin de la Société Voltaire n°5
Tilkin, Françoise ULg

E-print/Working paper (2003)

Detailed reference viewed: 5 (0 ULg)